Company Registration No. 08321724 (England and Wales)
UPPAL HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
UPPAL HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
UPPAL HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
1,341
6,937
Current assets
Debtors
5
200
200
Cash at bank and in hand
745,343
917,222
745,543
917,422
Creditors: amounts falling due within one year
6
(453)
(474)
Net current assets
745,090
916,948
Net assets
746,431
923,885
Capital and reserves
Called up share capital
7
200
200
Profit and loss reserves
746,231
923,685
Total equity
746,431
923,885

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 11 May 2026 and are signed on its behalf by:
Dr Manjinder Uppal
Director
Company registration number 08321724 (England and Wales)
UPPAL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

Uppal Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Kingswood House, 35 Orchehill Avenue, Gerrards Cross, Buckinghamshire, SL9 8QE.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
25% reducing balance
Computer equipment
33.33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

UPPAL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.5
Derivatives

Derivatives are initially recognised at fair value at the date a derivative contract is entered into and are subsequently remeasured to fair value at each reporting end date. The resulting gain or loss is recognised in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship.

A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.

1.6
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

The company operates an employee share ownership plan (ESOP) trust and has de facto control of the shares held by the trust and bears their benefits and risks. The company records assets and liabilities of the trust as its own. Consideration paid by the ESOP scheme for shares of the company is deducted from equity. Finance costs and administrative expenses incurred by the company in relation to the ESOP are recognised on an accruals basis.

1.7
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.8
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

UPPAL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2025 and 31 December 2025
79,490
Depreciation and impairment
At 1 January 2025
72,553
Depreciation charged in the year
5,596
At 31 December 2025
78,149
Carrying amount
At 31 December 2025
1,341
At 31 December 2024
6,937
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
200
200
UPPAL HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
(59)
(58)
Other creditors
512
532
453
474
7
Called up share capital
2025
2024
£
£
Ordinary share capital
Issued and fully paid
75 A Ordinary of £1 each
75
75
25 B Ordinary of £1 each
25
25
50 C Ordinary of £1 each
50
50
50 D Ordinary of £1 each
50
50
200
200
8
Directors' transactions

Dividends totalling £1,000 (2024 - £2,000) were paid in the year in respect of shares held by the company's directors.

2025-12-31 2025-01-01 false false false 12 May 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Dr Manjinder Uppal Jasvinder Uppal 08321724 2025-01-01 2025-12-31 08321724 2025-12-31 08321724 2024-12-31 08321724 core:OtherPropertyPlantEquipment 2025-12-31 08321724 core:OtherPropertyPlantEquipment 2024-12-31 08321724 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 08321724 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 08321724 core:CurrentFinancialInstruments 2025-12-31 08321724 core:CurrentFinancialInstruments 2024-12-31 08321724 core:ShareCapital 2025-12-31 08321724 core:ShareCapital 2024-12-31 08321724 core:RetainedEarningsAccumulatedLosses 2025-12-31 08321724 core:RetainedEarningsAccumulatedLosses 2024-12-31 08321724 core:ShareCapitalOrdinaryShareClass1 2025-12-31 08321724 core:ShareCapitalOrdinaryShareClass1 2024-12-31 08321724 core:ShareCapitalOrdinaryShareClass2 2025-12-31 08321724 core:ShareCapitalOrdinaryShareClass2 2024-12-31 08321724 core:ShareCapitalOrdinaryShareClass3 2025-12-31 08321724 core:ShareCapitalOrdinaryShareClass3 2024-12-31 08321724 core:ShareCapitalOrdinaryShareClass4 2025-12-31 08321724 core:ShareCapitalOrdinaryShareClass4 2024-12-31 08321724 core:ShareCapitalOrdinaryShares 2025-12-31 08321724 core:ShareCapitalOrdinaryShares 2024-12-31 08321724 bus:Director1 2025-01-01 2025-12-31 08321724 core:PlantMachinery 2025-01-01 2025-12-31 08321724 core:ComputerEquipment 2025-01-01 2025-12-31 08321724 2024-01-01 2024-12-31 08321724 core:OtherPropertyPlantEquipment 2024-12-31 08321724 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 08321724 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 08321724 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 08321724 bus:FRS102 2025-01-01 2025-12-31 08321724 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 08321724 bus:Director2 2025-01-01 2025-12-31 08321724 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP